Study: FDG-PET scans may lead to misdiagnosis of Alzheimer's

04/26/2012 | Medscape (free registration)

Sixty-five percent of patients in a community setting had a misdiagnosis or inconclusive data after an FDG-PET scan for Alzheimer's disease, with 35% having false-positive results, according to a study presented at a neurology meeting. The study indicates a need to standardize protocols for reading results, an expert said. Another expert has expressed concern over the findings, particularly with the arrival of new PET tracers for Alzheimer's.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Director of Governmental Programs
Bluegrass Family Health
Lexington, KY